Torren Management’s Fulgent Genetics FLGT Stock Holding History

Torren Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23	Closed	-$604	–	1153
2025 Q4	$604	Buy	+23	New	+$597	﹤0.01%	1301

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Torren Management's FLGT Position: Q1 2026 in Review

Torren Management sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 23 shares — an estimated $604 sold.

Torren Management first reported a position in FLGT in Q4 2025 and held it in 1 quarter. The position peaked at $604 in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

Torren Management reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
Torren Management sold 23 Fulgent Genetics shares in Q1 2026, an estimated $604.
Torren Management first reported a position in Fulgent Genetics in Q4 2025 and held it in 1 quarter.
Torren Management's Fulgent Genetics position peaked at $604 in Q4 2025.
157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.